(2S)-N-[(2R,3S)-6-amino-2-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]propoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide

C35H42N6O7 — CID 155707565

IUPAC(2S)-N-[(2R,3S)-6-amino-2-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]propoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide
SMILESC[C@@H](OCCCc1ccc2c(c1)n(C)c(=O)n2C1CCC(=O)NC1=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1Cc2cccc3c2N1C(=O)CCC3
InChIInChI=1S/C35H42N6O7/c1-20(24(12-15-29(36)42)37-34(46)28-19-23-9-3-7-22-8-4-10-31(44)41(28)32(22)23)48-17-5-6-21-11-13-25-27(18-21)39(2)35(47)40(25)26-14-16-30(43)38-33(26)45/h3,7,9,11,13,18,20,24,26,28H,4-6,8,10,12,14-17,19H2,1-2H3,(H2,36,42)(H,37,46)(H,38,43,45)/t20-,24+,26?,28+/m1/s1
InChIKeyXSVCNWSAQMVQSM-YRLZQNOSSA-N
MW658.76 g/mol
LogP1.70
Rot. Bonds12

About (2S)-N-[(2R,3S)-6-amino-2-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]propoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide

(2S)-N-[(2R,3S)-6-amino-2-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]propoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide (PubChem CID 155707565) has the molecular formula C35H42N6O7 and a molecular weight of 658.76 g/mol. Its IUPAC name is (2S)-N-[(2R,3S)-6-amino-2-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]propoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide.

Molecular Properties

Compound Name(2S)-N-[(2R,3S)-6-amino-2-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]propoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide
PubChem CID155707565
Molecular FormulaC35H42N6O7
Molecular Weight658.76 g/mol
Exact Mass658.31
IUPAC Name(2S)-N-[(2R,3S)-6-amino-2-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]propoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide
SMILESC[C@@H](OCCCc1ccc2c(c1)n(C)c(=O)n2C1CCC(=O)NC1=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1Cc2cccc3c2N1C(=O)CCC3
InChIInChI=1S/C35H42N6O7/c1-20(24(12-15-29(36)42)37-34(46)28-19-23-9-3-7-22-8-4-10-31(44)41(28)32(22)23)48-17-5-6-21-11-13-25-27(18-21)39(2)35(47)40(25)26-14-16-30(43)38-33(26)45/h3,7,9,11,13,18,20,24,26,28H,4-6,8,10,12,14-17,19H2,1-2H3,(H2,36,42)(H,37,46)(H,38,43,45)/t20-,24+,26?,28+/m1/s1
InChIKeyXSVCNWSAQMVQSM-YRLZQNOSSA-N
XLogP1.70
TPSA174.83 Ų
H-Bond Donors3
H-Bond Acceptors9
Rotatable Bonds12
Heavy Atoms48
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500658.76
LogP ≤ 51.70
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze (2S)-N-[(2R,3S)-6-amino-2-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]propoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-N-[(2R,3S)-6-amino-2-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]propoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide?
The IUPAC name of (2S)-N-[(2R,3S)-6-amino-2-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]propoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide (CID 155707565) is (2S)-N-[(2R,3S)-6-amino-2-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]propoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide.
What is the SMILES notation for (2S)-N-[(2R,3S)-6-amino-2-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]propoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide?
The canonical SMILES for (2S)-N-[(2R,3S)-6-amino-2-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]propoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide is C[C@@H](OCCCc1ccc2c(c1)n(C)c(=O)n2C1CCC(=O)NC1=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1Cc2cccc3c2N1C(=O)CCC3.
What is the InChIKey of (2S)-N-[(2R,3S)-6-amino-2-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]propoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide?
The InChIKey is XSVCNWSAQMVQSM-YRLZQNOSSA-N. The full InChI is InChI=1S/C35H42N6O7/c1-20(24(12-15-29(36)42)37-34(46)28-19-23-9-3-7-22-8-4-10-31(44)41(28)32(22)23)48-17-5-6-21-11-13-25-27(18-21)39(2)35(47)40(25)26-14-16-30(43)38-33(26)45/h3,7,9,11,13,18,20,24,26,28H,4-6,8,10,12,14-17,19H2,1-2H3,(H2,36,42)(H,37,46)(H,38,43,45)/t20-,24+,26?,28+/m1/s1.
What are the key properties of (2S)-N-[(2R,3S)-6-amino-2-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]propoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide?
(2S)-N-[(2R,3S)-6-amino-2-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]propoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide has a molecular weight of 658.76 g/mol, XLogP of 1.70, 12 rotatable bonds, 3 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-N-[(2R,3S)-6-amino-2-[3-[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]propoxy]-6-oxohexan-3-yl]-12-oxo-1-azatricyclo[6.4.1.04,13]trideca-4,6,8(13)-triene-2-carboxamide is sourced from PubChem (CID 155707565), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).